COUGHSPRAY: Effective Relief for dry and wet Cough

Claims

Mode of Action

The unique formulation of COUGHSPRAY targets throat irritation, and throat mucus accuumulation to deliver relief and soothing effects. Its mechanism of action operates through three key pathways:

Protective Barrier Effect: COUGHSPRAY forms a thin, protective film over the throat mucosa, regulating mucus adhesion in wet cough while shielding the irritated mucosa in dry cough. This barrier helps reduce throat discomfort and supports natural symptom relief

Osmotic and Cleaning Effect:  The product's high osmotic activity helps optimize mucus consistency in wet cough, facilitating natural clearance, while in dry cough, it maintains hydration, alleviating throat dryness and irritation.

Cellular Repair and Growth Effect: By creating a clean and hydrated biological surface, COUGHSPRAY immediately triggers cell growth and healing. This helps restore the integrity of the throat mucosa, further alleviating symptoms and promoting recovery.

Clinical Trial Results

The efficacy of COUGHSPRAY has been demonstrated in a randomized, double-blind, placebo-controlled trial over two weeks. The study included 54 patients, with 37 receiving the test product and 17 receiving the comparator. The results were impressive:

• Antibiotics: The requirement for antibiotics was significantly reduced in the test group (10.81% of patients) compared to the placebo group (82.35%).
• Severity: There was a 76% reduction in dry cough severity within 12 days.
• Frequency: There was a 98% reduction in dry cough frequency within 14 days.
• Throat Irritation: There was a 90% reduction in throat irritation within 12 days.
• Throat Pain: There was a 99% reduction in throat pain within 14 days.

These results demonstrate the effectiveness of COUGHSPRAY in providing rapid and lasting relief from the symptoms of cough, while also reducing the need for antibiotics. No side effects were recorded, further attesting to the safety of the product.

COUGHSPRAY by Vitrobio represents a new era in cough treatment, offering a safe, effective, and rapid solution to alleviate the symptoms and address the underlying causes of dry and wet cough.

See full publication (PDF)

Main results

ANTIBIOTICS
Requirements for antibiotics strongly diminished in the test group (10.81 % patients) vs placebo group (82.35 %)

SEVERITY
15,81 % reduction in dry cough severity within 2 days.
32,08 % reduction in dry cough severity within 3 days.
46,39 % reduction in dry cough severity within 6 days.
62,65 % reduction in dry cough severity within 9 days.
76 % reduction in dry cough severity within 12 days.

FREQUENCY
50 % reduction in dry cough frequency within 6 days.
80 % reduction in dry cough frequency within 12 days.
98 % reduction in dry cough frequency within 14 days.

THROAT IRRITATION
7,5 % reduction in throat irritation within 2 hours.
40 % reduction in throat irritation within 3 days.
60 % reduction in throat irritation within 6 days.
80 % reduction in throat irritation within 9 days.
90 % reduction in throat irritation within 12 days.

Throat irritation lower by 37,8 % within 3 days compare to the placebo group.
Throat irritation lower by 55,4 % within 6 days compare to the placebo group.
Throat irritation lower by 73,4 % within 9 days compare to the placebo group.
Throat irritation lower by 89,7 % within 12 days compare to the placebo group.

THROAT PAIN
19 % reduction in throat pain within 2 days.
38 % reduction in throat pain within 3 days.

56 % reduction in throat pain within 6 days.
72 % reduction in throat pain within 9 days.
86 % reduction in throat pain within 12 days.
99 % reduction in throat pain within 14 days.